Trinity Biotech ROE 2006-2019 | TRIB

Current and historical return on equity (ROE) values for Trinity Biotech (TRIB) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Trinity Biotech ROE for the three months ending September 30, 2019 was -10.96%.
Trinity Biotech ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-09-30 $-0.03B $0.04B -69.88%
2019-06-30 $-0.03B $0.04B -57.44%
2019-03-31 $-0.02B $0.04B -39.46%
2018-12-31 $-0.02B $0.04B -35.92%
2018-09-30 $-0.04B $0.07B -61.65%
2018-06-30 $-0.04B $0.07B -55.26%
2018-03-31 $-0.04B $0.07B -48.84%
2017-12-31 $-0.04B $0.07B -42.38%
2017-09-30 $-0.10B $0.11B -91.88%
2017-06-30 $-0.10B $0.11B -74.77%
2017-03-31 $-0.10B $0.11B -61.97%
2016-12-31 $-0.10B $0.11B -54.45%
2016-09-30 $0.00B $0.21B 1.42%
2016-06-30 $0.02B $0.21B 7.55%
2016-03-31 $0.02B $0.21B 8.08%
2015-12-31 $0.02B $0.21B 10.59%
2015-09-30 $0.02B $0.21B 11.30%
2015-06-30 $0.02B $0.21B 7.52%
2015-03-31 $0.02B $0.20B 8.11%
2014-12-31 $0.02B $0.20B 8.24%
2014-09-30 $0.02B $0.20B 8.91%
2014-06-30 $0.01B $0.20B 5.38%
2014-03-31 $0.01B $0.19B 5.54%
2013-12-31 $0.01B $0.18B 5.65%
2013-09-30 $0.01B $0.18B 5.19%
2013-06-30 $0.02B $0.18B 9.36%
2013-03-31 $0.02B $0.18B 9.57%
2012-12-31 $0.02B $0.17B 9.80%
2012-09-30 $0.02B $0.17B 10.08%
2012-06-30 $0.02B $0.16B 10.34%
2012-03-31 $0.02B $0.16B 10.56%
2011-12-31 $0.02B $0.15B 10.81%
2011-09-30 $0.02B $0.15B 11.00%
2011-06-30 $0.02B $0.15B 10.53%
2011-03-31 $0.06B $0.15B 44.60%
2010-12-31 $0.06B $0.14B 49.49%
2010-09-30 $0.06B $0.14B 55.68%
2010-06-30 $0.06B $0.13B 64.86%
2010-03-31 $0.01B $0.08B 15.53%
2009-12-31 $0.01B $0.08B 16.33%
2009-09-30 $-0.07B $0.08B -103.91%
2009-06-30 $-0.08B $0.07B -84.99%
2009-03-31 $-0.08B $0.07B -71.03%
2008-12-31 $-0.08B $0.07B -62.40%
2008-09-30 $-0.04B $0.15B -25.92%
2008-06-30 $-0.04B $0.15B -25.33%
2008-03-31 $-0.04B $0.14B -23.53%
2007-12-31 $-0.04B $0.14B -28.57%
2007-09-30 $0.01B $0.18B 6.15%
2007-06-30 $0.01B $0.18B 8.70%
2007-03-31 $0.01B 7.27%
2006-12-31 $0.00B $0.17B 4.85%
2006-09-30 $0.00B $0.16B 4.04%
2006-06-30 $0.00B 3.01%
2006-03-31 $0.01B 5.09%
2005-12-31 $0.01B $0.13B 3.88%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.022B $0.097B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.763B 27.14
Medtronic (MDT) Ireland $146.524B 20.57
Stryker (SYK) United States $76.003B 25.56
Boston Scientific (BSX) United States $57.941B 27.35
Baxter (BAX) United States $41.222B 25.00
EssilorLuxottica Societe Anonyme (ESLOY) France $33.507B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.830B 18.71
Terumo (TRUMY) Japan $26.321B 32.85
Lonza Group Ag (LZAGY) Switzerland $25.591B 0.00
Coloplast (CLPBY) Denmark $25.229B 40.28
ResMed (RMD) United States $20.909B 38.57
Smith & Nephew SNATS (SNN) United Kingdom $18.758B 0.00
Sunny Optical Technology (SNPTF) China $17.275B 0.00
Insulet (PODD) United States $10.935B 520.23
Bio-Rad Laboratories (BIO) United States $10.601B 50.88
Hill-Rom Holdings (HRC) United States $6.921B 20.39
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.539B 12.19
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.074B 41.04
Canopy Growth (CGC) Canada $5.519B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.748B 29.51
ICU Medical (ICUI) United States $3.612B 23.55
Aurora Cannabis (ACB) Canada $3.385B 0.00
Neogen (NEOG) United States $3.373B 56.45
GW Pharmaceuticals (GWPH) United Kingdom $3.275B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.046B 0.00
Quidel (QDEL) United States $2.573B 24.42
National Vision Holdings (EYE) United States $2.139B 48.27
Agios Pharmaceuticals (AGIO) United States $2.014B 0.00
Cardiovascular Systems (CSII) United States $1.492B 0.00
InMode (INMD) Israel $1.468B 0.00
VAREX IMAGING (VREX) United States $1.144B 22.91
AtriCure (ATRC) United States $1.111B 0.00
Aphria (APHA) $1.109B 0.00
Phibro Animal Health (PAHC) United States $0.924B 17.30
NanoString Technologies (NSTG) United States $0.848B 0.00
Lantheus Holdings (LNTH) United States $0.838B 20.93
TG Therapeutics (TGTX) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.74
Omeros (OMER) United States $0.687B 0.00
PetIQ (PETQ) United States $0.686B 16.72
LeMaitre Vascular (LMAT) United States $0.679B 38.13
Quanterix (QTRX) United States $0.631B 0.00
Cerus (CERS) United States $0.609B 0.00
Surmodics (SRDX) United States $0.531B 55.41
HEXO (HEXO) $0.486B 0.00
OraSure Technologies (OSUR) United States $0.485B 29.07
Owens & Minor (OMI) United States $0.414B 15.30
MacroGenics (MGNX) United States $0.410B 0.00
Organigram Holdings (OGI) Canada $0.386B 0.00
Utah Medical Products (UTMD) United States $0.368B 26.68
Meridian Bioscience (VIVO) United States $0.366B 12.59
BioLife Solutions (BLFS) United States $0.302B 122.92
Zynex (ZYXI) United States $0.302B 34.11
Bovie Medical (APYX) United States $0.266B 0.00
Viemed Healthcare (VMD) United States $0.254B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.247B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.196B 0.00
Repro-Med Systems (KRMD) United States $0.170B 0.00
Cytosorbents (CTSO) United States $0.138B 0.00
Rockwell Medical (RMTI) United States $0.134B 0.00
Fonar (FONR) United States $0.131B 9.23
Female Health (VERU) United States $0.125B 0.00
Chimerix (CMRX) United States $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
United-Guardian (UG) United States $0.089B 22.60
Chembio Diagnostics (CEMI) United States $0.076B 0.00
Nephros (NEPH) United States $0.066B 0.00
Surface Oncology (SURF) United States $0.052B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.044B 0.00
MTech Acquisition (KERN) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Senestech (SNES) United States $0.018B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00